Retinopathy is not the only ocular symptom: Myasthenia gravis in association with interferon therapy [14]

British Journal of Ophthalmology

Volumn 89, Issue 11, 2005, Pages 1542-1543

  Oishi, Akio ^a   Miyamoto, K ^a   Kashii, S ^a   Yoshimura, N ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; RIBAVIRIN;

AGED; CASE REPORT; DIPLOPIA; DISEASE ASSOCIATION; DIVERGENT STRABISMUS; HEPATITIS C; HUMAN; LETTER; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; RETINOPATHY; VERTICAL STRABISMUS;

AGED; ANTIVIRAL AGENTS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MYASTHENIA GRAVIS; RETINAL DISEASES;

EID: 27344449474     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2005.077537     Document Type: Letter

References (6)

1. Gurtubay IG, Morales G, Arechaga O, et al. Development of myasthenia gravis after Interferon alpha therapy. Electromyogr Clin Neurophysiol 1999;39:75-8.
2. Borgia G, Reynaud L, Gentile I, et al. Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C. J Interferon Cytokine Res 2001;21:469-70.
3. Weegink CJ, Chamuleau RA, Reesink HW, et al. Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin. J Gastroenterol 2001;36:723-4.
4. Konishi T. A case of myasthenia gravis which developed myasthenic crisis after alpha-interferon therapy for chronic hepatitis C. Rinsho Shinkeigaku 1996;36:980-5.
5. Harada H, Tamaoka A, Kohno Y, et al. Exacerbation of myasthenia gravis in a patient after interferon β treatment for chronic active hepatitis C. J Neurol Sci 1999;165:182-3.
6. Dumoulin FL, Leifeld L, Sauerbruch T, et al. Autoimmunity induced by interferon-α therapy for chronic viral hepatitis. Biomed Pharmacother 1999;53:242-54.